Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 252 Breast Neoplasms 197 Glioblastoma 196 Lung Neoplasms 195 Head and Neck Neoplasms 176 Squamous Cell Carcinoma of Head and Neck 166 Prostatic Neoplasms 164 Lymphoma 152 Rectal Neoplasms 132 Central Nervous System Neoplasms 119 Esophageal Neoplasms 117 Leukemia 111 Brain Neoplasms 100 Pancreatic Neoplasms 95 Precursor Cell Lymphoblastic Leukemia-Lymphoma 93 Gliosarcoma 86 Esophageal Squamous Cell Carcinoma 83 Lymphoma, Follicular 81 Sarcoma 80 Lymphoma, Large B-Cell, Diffuse 80 Uterine Cervical Neoplasms 76 Lymphoma, Non-Hodgkin 75 Hodgkin Disease 73 Neoplasms 68 Burkitt Lymphoma 67 Leukemia, Lymphocytic, Chronic, B-Cell 63 Colorectal Neoplasms 63 Glioma 61 Astrocytoma 60 Lymphoma, Large-Cell, Immunoblastic 58

Interventions

Ipilimumab 29 Nivolumab 23 pembrolizumab 14 incomplete Freund's adjuvant 10 Cyclophosphamide 10 Interleukin-2 9 Melphalan 8 CTLA-4 Antigen 8 sargramostim 7 Temozolomide 7 MART-1 Antigen 7 Dacarbazine 7 tebentafusp 6 Ranibizumab 6 montanide ISA 51 5 fludarabine phosphate 5 fludarabine 5 Sunitinib 5 Radiosurgery 5 Carboplatin 5 Bevacizumab 5 aldesleukin 4 aflibercept 4 Magnetic Resonance Spectroscopy 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Blood Specimen Collection 4 Biopsy 4 trametinib 3 sotrastaurin 3 relatlimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Uveal Melanoma × Radiotherapy × Clear all

NCT05893654 2025-09-15

MELCOM

Hospital das Clínicas de Ribeirão Preto

Phase 1/2 Enrolling by invitation

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡